Emma Lefrancais: Uncovering A Key Role for The IL-33/ST2 Axis in Platelet Biology with Lucie Gelon
Emma Lefrancais, Scientific Researcher at CNRS, shared on LinkedIn about a recent article by Lucie Gelon et al, published in Blood Advances:
”I’m delighted to share the publication of Lucie Gelon PhD work, available online at Blood Advances, uncovering a key role for the IL-33/ST2 axis in platelet biology:
‘The alarmin Interleukin-33 modulates platelet proteome, function and biogenesis’
Although platelets do not express IL-33, our study shows that IL-33 profoundly shapes their production and function.
We demonstrate that IL-33/ST2 signaling:
- remodels the platelet proteome, enriching inflammatory proteins
- impairs platelet adhesion and thrombus formation when absent
- accelerates platelet production in the lung by promoting megakaryocyte fragmentation within the vasculature
These mechanisms are likely to be particularly relevant during stress and aging, when IL-33–responsive megakaryocyte precursors expand.
Huge congratulations to Lucie Gelon for this great work at IPBS-Toulouse (CNRS-UT3), and many thanks to all co-authors and collaborators, Stéphane Roga, Jean-Philippe Girard, Anne Gonzalez de Peredo, Edith Vidal and Sonia Severin!”
Title: The alarmin Interleukin-33 modulates platelet proteome, function and biogenesis
Authors: Lucie Gelon, Stéphane Roga, Anne Gonzalez-de-Peredo, Edith Vidal, Jean-Philippe Girard, Sonia Severin, Emma Lefrançais
Read the Full Article on Blood Advances
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 21, 2026, 09:13Jarod Horobin: Blood 2026 – Connecting Science and People
-
Oct 21, 2026, 08:35Raeeda Gheewala: VTE in Athletes – Risks Beyond the Playing Field
-
Oct 21, 2026, 08:29Andreas Kronbichler: The Changing Landscape of CV Risk in ANCA-Associated Vasculitis
-
Oct 21, 2026, 08:21Pham Quy: Taking Stroke Awareness Beyond Hospitals and Into the Community
-
Oct 21, 2026, 07:15Mahmoud Saad: Successful Mechanical Thrombectomy for Right Atrial Thrombosis
-
Oct 21, 2026, 06:55Hunain Shahbaz: Extended Dual Antiplatelet Therapy Beyond 12 Months After Drug-Eluting Stent Implantation
-
Oct 21, 2026, 06:19Dawood Findakly: When Should Anticoagulation Be Held or Resumed?
-
Oct 21, 2026, 03:36Steve Watson: Ligand Epitope Ratios Influence Antagonist Inhibition
-
Oct 21, 2026, 03:18Stephen D. Coombs: Superficial Venous Thrombosis in Athletes and Importance of Early Recognition and Referral